Creative Planning
RCKT icon

Creative Planning’s Rocket Pharmaceuticals RCKT Stock Holding History

Creative Planning’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$780K Buy
217,851
+50,812
+30% +$202K ﹤0.01% 2664
2025
Q4 		$586K Buy
167,039
+12,054
+8% +$41.3K ﹤0.01% 2697
2025
Q3 		$505K Buy
154,985
+111,514
+257% +$351K ﹤0.01% 2709
2025
Q2 		$107K Sell
43,471
-36,130
-45% -$183K ﹤0.01% 3417
2025
Q1 		$531K Sell
79,601
-9,243
-10% -$91.3K ﹤0.01% 2227
2024
Q4 		$1.12M Buy
+88,844
New +$1.34M ﹤0.01% 1563
2017
Q2 		– Sell
-500
Closed -$4K – 4795
2017
Q1 		$4K Hold
500
– – ﹤0.01% 4069
2016
Q4 		$12K Sell
500
-750
-60% -$21.4K ﹤0.01% 3434
2016
Q3 		$47K Buy
+1,250
New +$39.3K ﹤0.01% 2412

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return